维普期刊资源整合服务平台（V6.5）

117篇 您的检索式：作者名="Pierga"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase Ⅱ randomized trial显示文摘	Pierga JY Bidard FC Mathiot C	2008	Clin Cancer Res2008，14，21：	1
2	Contemporary issues and the potential uses of capecitabine in metastatic breast cancer显示文摘	Lee P B Bidard F C Pierga J Y	2009	Cancer Treatment Reviews2009，35，7：	1
3	MO19391:An open-label safety study of bevacizumab plus taxane-based therapy as first-line treatment of patients with locally recurrent (LR) or metastatic breast cancer(MBC)显示文摘	Pierga J Pritchard KI Cortes-Funes H		0，，15：	1
4	Use of-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addi- tion of bevacizumab to neoadjuvant trastuzumab and doeetaxel in -FDG PET-predicted non-responders ( AVATAX- HER) : an open-label, randomised phase 2 trial显示文摘	Coudert B Pierga JY Mouret-Reynier MA	2014	Lancet On- col2014，15，13：	1
5	Response to Chemotherapy is a Major Parameter-influencing Long-term Survival of Metastatic Breast Cancer Patients 显示文摘	Pierga J Y Robain M Jouve M	2001	Ann Oncol2001，12，2：	1
6	Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients:clinical relevance显示文摘	Choesmel V Pierga JY Nos C	2004	Breast Cancer Res2004，6，5：	1
7	Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locallyadvanced breast cancer in a phase II randomized trial 显示文摘	Pierga JY Bidard FC Mathiot C	2008	Clin Cancer Res2008，14，21：	1
8	Clinical signifi- cance of irnmunocytochemical detection of rumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients显示文摘	Pierga JY Bonneton C Vincent-Salomon A	2004	Grin Cancer Res2004，10，4：	1
9	Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial显示文摘	Pierga JY Bidard FC Mathiot C	2008	Clin Cancer Res2008，，：	1
10	Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer显示文摘	Pierga JY Mouret E Dieras V	2000	Br J Cancer2000，83，11：	1
11	Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients 显示文摘	Pierga JY Bonneton C Vincent-Salomon A	2004	Clin Cancer Res2004，10，4：	1
12	Breast turnour response to primary chemotherapy predicts local and distant control as well as survival 显示文摘	SCHOLLS M PIERGA J Y ASSELAIN B	1995	Eur J Cancer1995，31，：	1
13	Prognostic factors foe survival after neoadjuvant chemotherapy in operable breast cancer:the role of clinical response显示文摘	Pierga JY Mouret E Lauernce V	2003	Eur J Cancer2003，，39：	1
14	Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients:clinical relevance显示文摘	Choesmel V Pierga JY Nos C	2004	Breast Cancer Res2004，6，5：	1
15	Characteristics and outcome of 1755 operable breast cancers in women over 70 years of age显示文摘	Pierga J Y Girre V Laurence V	2004	Breast2004，13，5：	1
16	Chemotherapy of metastatic endometral carcinoma,review of the literature显示文摘	Pierga JY Dieras V Paraiso D	1995	Bull Cancer1995，82，：	1
17	The impact of expression profiling on prognostic and predictive testing in breast cancer显示文摘	ReisFilho JS Westbury C Pierga JY	2006	J Clin Pathol2006，59，3：	1
18	Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients显示文摘	Pierga JY Bonneton C Vincent-Salomon A	2004	Clin Cancer Res2004，10，4：	1
19	Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial显示文摘	Pierga JY Bidard FC Mathiot C	2008	Clin Cancer Res2008，14，21：	1
20	Efficacy and safety of single agent capecitabine in pretreated metastatic breast cancer patients from the French compassionate use program显示文摘	Pierga JY Fumoleau P Brewer Y	2004	Breast Cancer Res Treat2004，88，2：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示